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Aston University, Birmingham B4 7ET, UK
This work introduces a new statistical physics lattice model of bacteria interacting with anti-
microbial drugs that can reproduce qualitative features of resistance emergence and whose model
parameters and outputs can be measured with controlled in vitro experiments. The lattice is in-
habited by agents modeled by Ising perceptrons. The results show the advantage of mixing drugs
among the population compared to other treatment protocols.
I. INTRODUCTION
Anti-microbial resistance (AMR), the resistance of in-
fectious micro-organisms to therapeutic drugs, has been
dramatically increasing during the last decades, becom-
ing a threat as dangerous as climate change [1, 2] and
potentially more urgent. With decreasing rates of anti-
microbial drug (AMD) development [3], we risk return-
ing to a defenseless era against infections. The issue is
so important that the World Health Organization has
proposed a global action plan to address it [4].
The focus of most studies lies on bacteria, which can
develop AMR in several ways. In addition to muta-
tions in their main DNA and the possibility of horizontal
gene transfer (HGT) through the intermediate action of
phages (bacteria-infecting viruses), they also possess cir-
cular DNA fragments, called plasmids, which frequently
encode resistance genes [5]. Plasmids can also mutate
like the main DNA and they largely contribute to HGT
[2, 6, 7] by being exchanged between bacteria of differ-
ent species or freed into the environment for instance,
upon cell death, once the cell’s membrane breaks down.
This versatility makes plasmids powerful tools for AMR
acquisition.
There are several attempted methods to deal with re-
sistance, although none of them has been enough to alle-
viate the problem satisfactorily. One common practice is
simply to avoid using of some AMD for which resistance
has emerged for a (potentially long) amount of time. Al-
though resistance seems to decrease in general with this
protocol, its efficiency has been disputed [8]. Evidence
shows that the reversal rate is slow [9, 10] and, even af-
ter some reversal is observed, AMR never goes back to
original levels.
Other common treatment protocols make simultaneous
use of more than one AMD [11], opening the doors for
the emergence of multiple resistance. The most popular
are the two-drug protocols called combining, mixing and
cycling. Combining AMDs amounts to administering the
two drugs simultaneously to all patients. Mixing means
that each drug is given separately to a certain fraction
of the patients, who keep taking the same drugh during
the whole treatment period. Finally, cycling entails the
periodic alternation between drugs, each one given to the
whole group at the same time.
There is a large literature on modeling AMR using dif-
ferential equations [11–15]. From the perspective of sta-
tistical physics, these are effective models, i.e., averages
over large populations. They have been used to predict
and analyze different aspects of AMR. However, as it
is common with effective models, they comprise a large
number of adjustable parameters as many of them have
to be included ad hoc to allow for a better adjusting of
observed features.
In microscopic models, on the other hand, the num-
ber of adjustable parameters is usually reduced as they
should emerge from microscopic quantities of the sys-
tem. While effective models can be advantageous from
the practical point, once their solution has usually a lower
computational cost, microscopic models help in under-
standing basic principles behind the phenomenon, lead-
ing possibly to a better control and refinements or cor-
rections to the effective models.
AMR and evolution of cell cultures have been ad-
dressed in different branches of theoretical physics be-
fore, but most models were again effective ones [16–18].
The use of microscopic models has been far less com-
mon [19, 20]. Analytical results from related statistical
physics evolutionary models also exist, but AMR is not
specifically addressed [21].
Given the importance of the subject, it is surprising
that the powerful methods of statistical physics have not
been more widely applied to the AMR problem. This
paper contributes to fill this gap by introducing a new
microscopic model of agents in a lattice. Using fewer pa-
rameters than models relying on differential equations, it
is capable of reproducing qualitatively main features of
AMR. It is clear that simplified models like the present
one cannot reproduce perfectly all the subtleties of the
biological processes involved in AMR. In this first ap-
proximation though, the aim of this work is to repro-
duce mainly qualitative aspects and understand the fun-
damental mechanisms at work. Quantitative agreement
with experiments requires more thorough studies and
model refinement.
In section II we introduce the lattice model repre-
senting an artificial bacteria culture in a Petri torus.
The model has only three parameters representing a
genotype-phenotype map from the cell’s plasmid to their
response to AMDs. The introduced model is used to an-
alyze the effect of the single drug protocol in section III,
where it is shown that it can reproduce the memory ef-
fect we mentioned above. Section IV shows the results for
double-drug protocol in which we single out the mixing
2protocol as the best option to slow down the emergence
of resistance. Finally, further discussions and conclusions
are presented in section V.
II. ARTIFICIAL BACTERIA
The model presented here corresponds to a scenario in
which a bacterial culture in a Petri dish is subjected to
different treatments with different AMDs. The evolution
of the culture in time is then followed in order to pro-
vide information about how each treatment affects the
dynamical aspects of AMR emergence in the culture.
For convenience, the Petri dish is represented in a sim-
plified way by a squareN×N lattice with periodic bound-
ary conditions (PBC) in both directions, which is going
to be called a Petri torus due to the resulting topology.
To each site (i, j), i, j = 1, ..., N , a spin variable σij which
is +1 if the site is occupied by a cell and -1 if it is empty.
PBC imply σi+N,j = σi,j+N = σij .
The main bacterial life cycle, excluding the action of
the AMDs, is modeled by two parameters. At each time
step t, cells reproduce by choosing one of its four neigh-
boring sites with the same probability. If the site is
empty, then there is a probability r for the cell to di-
vide with the newborn bacteria occupying the new site.
A natural death probability d for each living cell at time t
is used to model all non-drug related processes like other
adverse environmental conditions, the natural life-cycle
of the cell and a patient’s immune system.
Bacteria are modeled as agents living in the Petri torus
subjected to external stimuli provided by local concen-
trations of the different AMDs. The drugs are adminis-
tered according to each specific treatment protocol to
be analyzed. Pharmaceutical companies usually mea-
sure the efficiency of particular AMDs by their Mini-
mum Inhibitory Concentration (MIC), the drug concen-
tration above which bacterial growth stops on average
[22]. The MIC is convenient in clinical trials as it avoids
the difficulties in isolating the effects of patients’ immune
system, but it contains no information about pharmaco-
dynamic properties of the drug (how bacterial growth
changes with variations in drug concentrations). It has
been proposed that a better proxy is given by the Mini-
mum Bactericidal Concentration (MBC), the concentra-
tion that kills at least 99.9% of the bacteria on aver-
age [23]. Here, a variation of the MBC is proposed and
used: the concentration below which no cell dies. This
definition is much simpler to implement in a probabilis-
tic microscopic model and, because the studied scenario
comprises in vitro cultures, it can be actually measured
with controlled experiments.
Finally, it is assumed for simplicity that each cell has
one single plasmid encoding its AMD response, which is
given by the total AMD death probability qµij , the prob-
ability that the cell occupying the site (i, j) dies if ex-
posed to the local concentration cµij of the µ-th AMD,
µ ∈ {1, ...,M}, where M is total number of different
available AMDs. This probability is modeled by
qµij = Θ
(
∆µij
)
pµij
(
1− e−λ
µ
ij
∆
µ
ij
)
. (1)
where ∆µij ≡ c
µ
ij − c¯
µ
ij .
There are only three parameters in the above expres-
sion, what is already a huge simplification if compared
to the models based on differential equations. The MBC
c¯µij ∈ [0,∞), enters in the model through the Heaviside
step function Θ(x), which is zero if x < 0 and 1 other-
wise. Its objective is to account for physical and chemical
mechanisms having threshold behaviors as, for instance,
chemical pumps which can become saturated or mem-
branes whose thickness up to a certain point can prevent
the AMDs from entering the cell interior. The maximum
death probability pµij ∈ [0, 1] is a scaling that sets the
maximum damage a certain AMD can inflict to the cell.
Finally, the sensitivity λµij ∈ [0,∞) regulates the increase
in cell death with AMD concentration and is related to
the actual toxicity of it. All three parameters can, in
principle, be obtained from actual designed experiments
by measuring changes in bacterial populations.
The genotype of each plasmid will be encoded by a spin
chain piij ∈ {±1}
D
, where D is an integer. The crucial
point in epigenetics is to find an appropriate genotype-
phenotype map into the model parameters [24, 25]. The
map should allow for different genotypes to generate the
similar phenotypes and also for learning and forgetting.
Learning is required for adaptation in the form of AMR
acquisition and forgetting allows acquired adaptations to
fade away, as would be the case for reversal of AMR. One
of the most studied statistical physics models of biological
phenomena with these characteristics is the Ising percep-
tron [26, 27], designed to model neuronal responses, with
the neuron’s synapses and stimuli both encoded by spin
chains.
The perceptron is one of the simplest known learning
machines and it is characterized by a function taking a
multidimensional vector into a number, called the acti-
vation function for biological reasons. This is usually
a general function of the scalar product of its synaptic
vector, which is a multidimensional parameter encoding
the information learned by the perceptron, and the input
vector, a vector with the same dimensions as the synap-
tic vector and which encodes the stimuli provided by the
environment to which the perceptron reacts.
In this work, the input vectors correspond to the binary
encodings of each AMD into a spin chain of dimension
3D, Aµ = (αµ,βµ,γµ) ∈ {±1}3D. The three model
parameters are then given by
c¯µij =
1 + φµij
1− φµij
, φµij =
αµ · piij
D
, (2)
λµij =
1 + ξµij
1− ξµij
, ξµij =
βµ · piij
D
, (3)
pµij =
1 + ωµij
2
, ωµij =
γµ · piij
D
, (4)
3which are chosen for being the simplest mappings into
the relevant intervals.
Although simple perceptrons cannot approximate gen-
eral functions, it has been shown that adding one extra
layer, corresponding to another set of perceptrons real-
ising an intermediate processing of information between
the stimuli and the final response, turns them into uni-
versal approximators [28]. Variations with several layers,
known as deep neural networks, have been successfully
used in machine learning applications and recently pro-
vided a solution for the long sought problem of creating
a computer algorithm capable of playing Go on a level
comparable to human masters [29].
The dimension of the AMD vector was chosen to be
three times larger than the plasmid’s one to allow muta-
tions in the latter to simultaneously affect all three model
parameters. In nature, each protein usually participates
in more than one metabolic process simultaneously. As
a consequence, each single mutation might affect more
than one of them.
One should notice that, although p, c¯ and λ are being
called the parameters of the model, they are actually not
numeric adjustable parameters. Once the genotype and
the AMD are chosen, they are fully determined. More
precisely, the only freedom comes from the choice of the
activation functions leading to them. One might call the
latter the functional parameters of our model, as it re-
mains open the possibility of choosing more complicated
genotype-phenotype maps which might lead to better
agreement between observation and theory if needed.
III. SINGLE RESISTANCE
In order to obtain the dynamical behaviour of the
AMD death probability q for one single drug, the model
is simulated in discrete time t. Each initial Petri torus
occupation is set by putting a cell in each site with proba-
bility 1/2. All initial cells carry the same all-ones plasmid
pi = 1 ≡ (1, 1, ..., 1). To isolate the effect of the AMD,
we will use r = 1 and d = 0, i.e., cells always repro-
duce if there is space and do not die unless killed by the
AMD. With these two parameters fixed to these values,
the dynamics then follows two steps at each t:
(1) Reproduction: all living cells are drawn once and only
once with the same probability. Then, one of the four
neighbors of that cell is chosen with probability 1/4 and,
if the corresponding site is empty, the cell generates a
child cell on it. The child cell has a probability m of mu-
tation, where one single coordinate of its plasmid, chosen
at random with equal probability, is flipped.
(2) AMD Death: in a uniformly random order, one checks
whether each cell dies according to the probability qµij for
each AMD present locally.
Each run of the simulation consists of T time steps and
the information recorded is a double average of the death
probability qµij - the average over all living cells and the
quenched average over initial configurations.
FIG. 1. Fitness landscape. The plot shows the fitness
landscape for the AMD (−1,−1,1) as a contour plot rep-
resenting the total death probability q as a function of the
AMD concentration c and the fraction x of -1 coordinates in
the plasmid. The landscape shows a global maximum of q at
the centre extending to the top of the graph surrounded by
decreasing profiles to both side. While higher concentrations
will eventually kill all cells leading to q = 1, one can see that
by changing x in any direction decreases q and, therefore,
increases resistance.
According to our model, bacteria acquire resistance
by (i) increasing the MBC, (ii) decreasing the maximum
death probability, (iii) decreasing their sensitivity to the
drug or any combination of these. Although the same
mechanisms can contribute to different parameters, the
larger the plasmid dimension D is, the more uncorrelated
we expect them to be.
It is clear that for large dimensionsD, which is the case
in practice, the fitness landscape will be highly AMD
dependent. It is reasonable to expect it to b also very
complex, with several local minima and maxima which
cannot be easily studied only with analytical methods. In
order to get some insight into these landscapes, we start
our analysis by illustrating how one can use the model
to extract useful information in simple cases. One such
case is the choice αi = βi = −1 and γi = 1, i = 1, ..., D,
in which the parameters can be expressed as
c¯ = λ =
x
1− x
, and p = 1− x, (5)
where x = n/D and n is the fraction of -1 coordinates in
the plasmid. When D →∞, x becomes a continuous real
variable in the interval [0, 1]. In this case it becomes very
simple to plot the fitness landscape as a contour plot of q
as a function of x and the AMD concentration c as given
in fig. 1.
In this particular case, c¯ and λ are equal by design,
which will usually not be the case in practice. Still, qual-
itatively this is an important situation where they both
contribute in different ways for the emergence of AMR.
While a higher MBC improves resistance, a higher sen-
sitivity decreases it. This is reflected in the fitness land-
4FIG. 2. Average death probability q as a function of time t for
three different mutation rates (labels near each corresponding
line). Shaded areas around the curves represent variances.
scape by the maximum of q surrounded by descending
profiles both to the left and right. Because this landscape
has a only one global maximum, we can more clearly see
that resistance will eventually emerge as we move away
from it in the x direction, which is always observed in
simulations.
For the rest of this work, we use AMDs with D = 70
where α and β are generated randomly and uniformly.
Without loss of generality, we set γi = 1 to tune the ini-
tial value of p to 1. Fig. 2 shows the average death prob-
ability q for mutation rates m = 0.4, 0.1, 0.04 in a lattice
of size N = 100. Results are averaged over K = 100 re-
alizations of the same AMD, differing by the initial site
occupation, and over Na = 10 different randomly gener-
ated AMDs. Averaging over AMDs drastically increases
the deviations from the mean curves as the response to
each might be very different for the same plasmid. The
local concentrations of AMD are kept constant during
simulations, fine-tuned to give an initial q = 0.5. As ex-
pected, larger mutation rates allow for faster adaptation
(smaller q). The shadowed areas around the mean curves
represent deviations from mean plots and, as discussed
before, it is clear the dramatic increase in their amplitude
as the mutation rate is decreased.
Because the death probability is restricted to the in-
terval ∈ [0, 1], deviations above and below the mean are
calculated separately. Let q¯kl be the average death prob-
ability for the k-th run of the l-th AMD. Deviations above
and below the mean are respectively
σ2+ =
1
n+
∑
k,l
Θ(∆qkl)(∆qkl)
2, (6)
σ2
−
=
1
n
−
∑
k,l
[1−Θ(∆qkl)](∆qkl)
2
, (7)
where ∆qkl = q − q¯kl, n+ and n− are the number of
cases in which the variation is respectively non-negative
or negative.
FIG. 3. Average death probability q as a function of time t
for m = 0.4. Each treatment is stopped at a different time
(curve labels). The bottom line shows a continuing treatment.
Shaded areas around curves represent deviations.
Deviations become larger for smaller mutation rates
m because different AMDs lead to very different rates of
emergence. With higherm, cells probe larger areas of the
fitness landscape before dying, resulting in faster growth
of AMR. Higher initial concentrations require greaterm’s
for adaptation to win over extinction. The exact rela-
tionship between this threshold and the other parame-
ters of the model requires a better characterization of
the phase diagram, which is under study. Realistically,
higher concentrations become toxic also to the patients
and, although efficient to kill bacteria, might result in
potentially fatal side effects.
Fig. 3 reproduces the observed memory effect that
stopping the treatment does not restore resistance to its
levels before its beginning. The same parameters as be-
fore are used, but only for m = 0.4, averaging over 10
AMDs. Stopping times are written next to the corre-
sponding curves, the bottom one representing a continu-
ing treatment.
IV. DOUBLE RESISTANCE
While it seems logical to use several AMDs simultane-
ously, as the probability of being resistant to all of them
is surely smaller than to a single one, this creates a mul-
tiple selection pressure that might lead to the emergence
of resistance to all of them. To study this, we simulate
the currently most common two-drug protocols: (i) com-
bining, (ii) mixing and (iii) cycling.
Fig. 4 compares the rate of emergence of resistance
when only one AMD (Single) is used against that of the
three two-drug protocols. The curves are averages over
100 random initial occupations of the lattice and 10 ran-
domly generated pairs of AMDs. Each AMD is generated
independently, its coordinates being ±1 with equal prob-
abilities. The plot shows only the first AMD of each pair.
The results for the second vary slightly quantitatively,
5FIG. 4. Average death probability q as a function of time t
for different protocols: single AMD, combining, mixing (indi-
cated by labels) and cycling (spiked curves) with periods 10,
50 and 100. In multi-drug protocols, only one of the AMDs is
shown. Shaded areas around curves indicate deviations. Sim-
ulations were run for initial (a) q = 0.5 and (b) q = 0.3 and a
mutation rate m = 0.4 in a lattice with 10000 sites.
but the qualitative behavior is similar.
All protocols were applied using the same initial death
probability, q = 0.5 for the upper plot and q = 0.3 for
the bottom one. N = 100 and m = 0.4 for both. Again,
shaded areas around curves represent deviations above
and below mean values.
For the combining protocol, both AMDs are present
at each site simultaneously. Concentrations are site in-
dependent and do not vary with time. For the mixing
protocol, only one AMD is present at each site. For ev-
ery site, we choose one AMD of the pair with probability
1/2 and keep its concentration constant in time. All sites
with the same AMD have the same drug concentration.
For cycling, the simulation starts with the first AMD in
each pair present in all sites at the same concentration.
After each cycling period C, the AMD is changed by the
other one in the same pair in all sites. Results are pre-
sented for three different periods, C = 10, 50 and 100.
For the chosen parameters, combining shows very little
emergence when q = 0.5. However, this is mainly a result
of the double concentration to which cells are exposed.
FIG. 5. Average death probability q as a function of time t for
cycling with period C = 50 for both AMDs in the pairs for
the same parameters as in fig. 4b.
Because the initial q is relatively high for both AMDs,
cells die faster than they can adapt. Mixing seems to
be the next best, with an apparent asymptotic stop of
resistance emergence. Although the cycling protocols do
better than the single drug case, they seem to be unable
to avoid the emergence of total resistance, which in this
case occurs for both AMDs. In particular, this is indepen-
dent of the cycling period, whose only effect is to create
larger oscillations about an average line roughly coincid-
ing with the smaller cycle. For cycling, we see again
the memory effect discussed in the introduction: when
one AMD is not being used, resistance decreases but not
enough to bring a complete recovery to initial levels. It is
not clear if there is any influence of the second AMD in
the recovery, an interesting question for further studies.
For the plot in fig. 4b, simulations start with q = 0.3
by appropriately adjusting the AMD concentrations. Dif-
ferently from the previous case, combining becomes the
worst of the multi-drug protocols, worse even than the
single-drug one after some time. This change is explained
by noticing that with q = 0.3, cells live long enough to
allow AMR to appear through mutations. The data indi-
cates again that, while other protocols result in the emer-
gence of an almost total resistance, mixing saturates at
a lower level for the given parameters.
Fig. 5 shows the same graph for the two drugs of the
pair for a cycling protocol with period C = 50. The first
AMD in the pair is represented by the line which drops
faster in the initial period.
We measured the joint pharmacodynamics of a certain
AMD pair by the average relative sign of their variations
of q
ρ(t) =
1
KNa
∑
k,l
sgn
(
∆q¯1kl(t)∆q¯
2
kl(t)
)
, (8)
where sgnx = x/|x| if x 6= 0 and 0 otherwise, ∆q¯µkl(t) =
q¯µkl(t)− q¯
µ
kl(t−1) and q¯
µ
kl(t) is the death probability aver-
aged only over lattice sites for the µ-th AMD in the l-th
6FIG. 6. Average value of the relative sign of the variations in
q between the two AMDs in each pair. Results for combining
and mixing are labeled in the plot. Spiked curves represent
cycling with three different periods – 25, 50 and 100 steps –
easy to identify due to the periodic behaviors. The simulation
parameters are the same as in fig. 4b.
pair during the k-th simulation run at time step t.
This quantity, plotted in fig. 6 for each two-drug proto-
col (using the same parameters as in fig. 4b), shows how
often on average the cells have the same adaptive trend
towards resistance to the two drugs in the pair. The value
+1 means that both q change in the same direction, i.e.,
bacteria are either becoming resistant or more suscepti-
ble to both AMDs simultaneously. Conversely, -1 means
that their adaptive trend is opposite, they are gaining
resistant to one of them and losing to the other.
The results indicate that when both AMDs are simul-
taneously present, resistance changes in the same direc-
tion for longer than in cycling, but this is not enough
for the latter to outperform mixing. Mixing remains su-
perior because, when reproducing, cells will half of the
time spread to a site with a different AMD, to which
they are less resistant. Although this seems similar to
cycling, the latter has the whole population subjected to
the same AMD at every time step.
We now analyse a new protocol, mixed cycling, which
in principle should combine the advantages of mixing and
cycling: we distribute two AMDs uniformly randomly to
the population and then cycle the resulting configuration.
Fig. 7 shows a comparison between this protocol and
mixing.
The plot, in which the same parameters as in fig. 4b
were used and where the cycling period was chosen to
be C = 50, shows the results for the first AMD in the
pair. One can see that mixed cycling ends up performing
worse than mixing. Unexpectedly, instead of observing a
reversal in resistance at each cycling period, the change
in AMD has exactly the opposite effect: it increases the
AMR emergence rate. The mechanism at work here is
subtle, but at the same time very simple. With pure
cycling, each period sees adaptation to only one AMD,
while the other loses it. Resistance is reversed because
FIG. 7. Comparison between mixed cycling and (plain) mix-
ing with the same parameters as in fig. 4b and cycling period
of 50 steps. Mixed cycling is not enough to outperform mix-
ing with AMR emergence rates surprisingly being increased
for each cycling period instead of decreasing as for pure cy-
cling.
no cell is under pressure to adapt to the absent AMD.
On the other hand, in every cycling period of mixed
cycling, half of the cells are subjected to one AMD and
half to the other. This implies that adaptation to both,
although at a smaller rate, is always taking place. Still,
that does not explain the whole story as, in the mixing
protocol, both AMDs are also present all the time dur-
ing the runs. The difference is that each cell which has
already adapted in mixing, will not suffer any different
pressure as the AMD at that site never changes. On the
other hand, with the cycling, it is force to re-adapt. That,
instead of decreasing AMR, works in its favor. The de-
tails of this mechanism need to be studied more carefully
and is the subject of our current research.
V. CONCLUSIONS
The model presented here has many advantages com-
plementary to usual ones based on differential equations.
Being a microscopic statistical model, there is larger con-
trol over mechanisms for AMR emergence. It also bene-
fits from clarity and versatility while, at the same time, it
can reproduce qualitatively actual features of both single
and double resistance to arbitrary AMDs using very few
parameters.
Additional mechanisms, like exchange or acquisition of
plasmids, are easy to include in the model. One exciting
possibility is to use machine learning algorithms to en-
code the structure of actual AMDs and study them. The
plasmid genotype can be directly translated to binary
code and the macroscopic parameters of the model can
be obtained from experiments. Although perceptrons are
too simple to approximate general genotype-phenotype
maps, it was proven [28] that more complex networks, as
deep networks [29], are universal approximators and can
7become powerful tools in the search of real new AMDs
and evaluation of resistance scenarios.
By applying the model to the most commonly used
treatment protocols, we showed that the model (i) is ca-
pable of producing single and double resistance and (ii)
can reproduce the memory effects observed in practice
which indicates that reversal rates in the absence of AMD
are inefficient to recover initial levels of resistance.
The simulations that have been carried out indicate
that the mixing protocol is the most efficient of the pro-
tocols. The reason seems to be deceptively simple: while
in all other protocols the whole population is subjected
to the same AMD for some period of time, resistance
grows faster during these times as all bacteria evolve in
the same direction. With mixing, half of the population
adapts mainly to one AMD and the other half to an-
other. In addition, whenever bacteria spread, they have
a chance of meeting a different AMD than the one in its
original site, which changes the adaptation trend. Evi-
dence in favour of this explanation comes from the pro-
posed mixed cycling protocol. One could expect that this
would benefit from the advantages of both mixing and cy-
cling. In particular, the reversal in resistance observed at
each cycling period. However, because of the mixing in
the population, when the cycling period is reached, half
of the bacteria are still subjected to the same AMD and,
although slower, adaptation continues leading to resis-
tance. On the other hand, contrary to mixing, all bacte-
ria are exposed to both AMD, although in different peri-
ods. Because of this, cells at a definite site have contact
to both AMDs instead of only one as in mixing, which
leads to higher average adaptation to both.
Other statistical physics issues need further analysis as,
for instance, finite size effects and the existence or not of
true phase transitions to resistant phases. HGT might be
an important issue as it is known to change the critical
transition point for speciation [30] and should also affect
significantly AMR emergence.
Many qualitative aspects of the model are fairly gen-
eral and actual experiments are fundamental in testing
its predictions as well as identifying aspects in which a
more sophisticated modeling is needed in order to allow
for a closer approximation of practical situations.
ACKNOWLEDGEMENTS
I would like to thank Dr J. Neirotti, Dr M.Stich, Dr
M.Chli and Dr A. Cheong for their suggestions and dis-
cussions.
[1] N. Woodford and D. M. Livermore, Journal of Infection
59, S4 (2009).
[2] D. I. Andersson and D. Hughes, Nature Reviews Micro-
biology 8, 260 (2010).
[3] P. G. Charles and M. L. Grayson, Medical Journal of
Australia 181, 549 (2004).
[4] Global Action Plan on Antibiotic Resistance, Tech. Rep.
(World Health Organisation/UNO, 2015).
[5] J. W. Ng, D. Chatenay, J. Robert, and M. G. Poirier,
Phys. Rev. E 81, 011909 (2010).
[6] A. San Millan, M. Toll-Riera, Q. Qi, and R. C. MacLean,
Nature Communications 6 (2015).
[7] D. A. Baltrus, Trends in Ecology & Evolution 28, 489
(2013).
[8] T. M. Barbosa and S. B. Levy, Drug Resistance Updates
3, 303 (2000).
[9] D. J. Austin, K. G. Kristinsson, and R. M. Anderson,
Proceedings of the National Academy of Sciences 96,
1152 (1999).
[10] L. Tan, S. Serene, H. X. Chao, and J. Gore, Phys. Rev.
Lett. 106, 198102 (2011).
[11] S. Bonhoeffer, M. Lipsitch, and B. R. Levin, Proceedings
of the National Academy of Sciences 94, 12106 (1997).
[12] M. E. Alexander, C. S. Bowman, Z. Feng, M. Gardam,
S. M. Moghadas, G. Ro¨st, J. Wu, and P. Yan, Proceed-
ings of the Royal Society of London B: Biological Sciences
274, 1675 (2007).
[13] E. M. D’Agata, M. Dupont-Rouzeyrol, P. Magal,
D. Olivier, and S. Ruan, PLoS One 3, e4036 (2008).
[14] U. Obolski and L. Hadany, BMC Medicine 10, 89 (2012).
[15] L. Ternent, R. J. Dyson, A.-M. Krachler, and S. Jabbari,
Journal of Theoretical Biology 372, 1 (2015).
[16] P. Patra and S. Klumpp, Phys. Rev. E 89, 030702 (2014).
[17] G. Lambert and E. Kussell, Phys. Rev. X 5, 011016
(2015).
[18] P. Bittihn, J. Hasty, and L. S. Tsimring, Phys. Rev. Lett.
118, 028102 (2017).
[19] R. Hermsen and T. Hwa, Phys. Rev. Lett. 105, 248104
(2010).
[20] P. Greulich, B. Waclaw, and R. J. Allen, Phys. Rev.
Lett. 109, 088101 (2012).
[21] M. Tikhonov and R. Monasson, Phys. Rev. Lett. 118,
048103 (2017).
[22] P. G. Davey, M. H. Wilcox, W. L. Irving, G. Thwaites,
et al., Antimicrobial chemotherapy (Oxford University
Press, USA, 2015).
[23] G. French, Journal of Antimicrobial Chemotherapy 58,
1107 (2006).
[24] P. F. Stadler and B. M. Stadler, Biological Theory 1, 268
(2006).
[25] R. Cortini, M. Barbi, B. R. Care´, C. Lavelle, A. Lesne,
J. Mozziconacci, and J.-M. Victor, Rev. Mod. Phys. 88,
025002 (2016).
[26] F. Rosenblatt, Psychological Review 65, 386 (1958).
[27] A. Engel and C. van den Broeck, Statistical Mechanics
of Learning (Cambridge University Press, 2001).
[28] G. Cybenko, Mathematics of Control, Signals and Sys-
tems 2, 303 (1989).
[29] D. Silver, A. Huang, C. J. Maddison, A. Guez, L. Sifre,
G. Van Den Driessche, J. Schrittwieser, I. Antonoglou,
V. Panneershelvam, M. Lanctot, et al., Nature 529, 484
(2016).
[30] J.-M. Park and M. W. Deem, Phys. Rev. Lett. 98, 058101
(2007).
